Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Ann Neurol. 2023 Apr 19;94(1):146–159. doi: 10.1002/ana.26649

TABLE 3.

Neurologic Symptoms and Signs Attributed to Long COVID in Post-hospitalization and Non-hospitalized Neuro-PASC Patients

Overall Post-hospitalization
Neuro-PASC (PNP)
Non-hospitalized
Neuro-PASC (NNP)
p-Value
Time from symptom onset to clinic visit (month, mean (1 SD)) 6.8 (3.69) 7.3 (3.9) 6.7 (3.6) 0.14
Subjective impression of recovery compared to pre-COVID-19 baseline (mean % (1 SD)) 59.8 (23.4) 55.7 (23.7) 60.6 (23.4) 0.07
n = 92 n = 475
No. of neurologic manifestations/symptoms attributed to COVID-19 (median [IQR]) 7 [5–10] 7 [5–9] 7 [5–10] 0.38
Neurologic symptom n (%)
 ≥4 543 (91) 89 (89) 454 (90.8) 0.58
 Brain fog 487 (81.2) 86 (86) 401 (80.2) 0.21
 Headache 422 (70.3) 63 (63) 359 (71.8) 0.09
 Anosmia 334 (55.7) 39 (39) 295 (59) 0.0003
 Dysgeusia 327 (54.5) 39 (39) 288 (57.6) 0.0009
 Dizziness 297 (49.5) 49 (49) 248 (49.6) 1
 Myalgia 285 (47.5) 33 (33) 252 (50.4) 0.002
 Numbness/tingling 253 (42.2) 51 (51) 202 (40.4) 0.06
 Pain other than chest 243 (40.5) 39 (39) 204 (40.8) 0.82
 Tinnitush 172 (28.7) 29 (29) 143 (28.6) 1
 Blurred vision 156 (26.0) 23 (23) 133 (26.6) 0.53
 Seizure 8 (1.3) 3 (3) 5 (1) 0.13
 Movement disordera 7 (1.2) 1 (1) 6 (1.2) 1
 Ischemic Stroke 7 (1.2) 2 (2) 5 (1) 0.33
 Encephalitis 2 (0.3) 1 (1) 1 (0.2) 0.31
 Focal motor deficitb 1 (0.2) 0 (0) 1 (0.2) 1
 Focal sensory deficit 1 (0.2) 1 (1) 0 (0) 0.17
 Hemorrhagic stroke 1 (0.2) 0 (0) 1 (0.2) 1
 Meningitis 1 (0.2) 1 (1) 0 (0) 0.17
 Polyradiculitisc 1 (0.2) 1 (1) 0 (0) 0.17
Other symptom n (%)
 Fatigue 515 (85.8) 84 (84) 431 (86.2) 0.53
 Depression/Anxiety 416 (69.3) 69 (69) 347 (69.4) 1
 Insomnia 342 (57.0) 60 (60) 282 (56.4) 0.58
 Shortness of breath 290 (48.3) 72 (72) 218 (43.6) <0.0001
 Dysautonomiad,i 204 (34.0) 35 (35) 169 (33.8) 0.82
 Chest pain 178 (29.7) 41 (41) 137 (27.4) 0.008
 GI symptomse 162 (27.0) 21 (21) 141 (28.2) 0.17
Sign n/n tested (%)
 Abnormal exam 233/563 (41.4) 61/98 (62.2) 172/465 (37.0) <0.0001
 Short-term memory deficit 135/563 (24.0) 37/98 (37.8) 98/465 (21.1) 0.0007
 Attention deficit 66/563 (11.7) 22/98 (22.4) 44/465 (9.5) 0.0008
 Sensory dysfunctionf 47/563 (8.3) 18/98 (18.4) 29/465 (6.2) 0.0004
 Gait dysfunction 33/563 (5.9) 16/98 (16.3) 17/465 (3.7) <0.0001
 Motor dysfunction 24/563 (4.3) 13/98 (13.3) 11/465 (2.4) <0.0001
 Cranial nerve dysfunctiong 20/563 (3.6) 5/98 (5.1) 15/465 (3.2) 0.37
 Movement disorder 11/563 (2.0) 3/98 (3.1) 8/465 (1.7) 0.42
 Cerebellar dysfunction 5/563 (0.9) 3/98 (3.1) 2/465 (0.4) 0.04
a

PNP: Self-reported abnormal movement (3). NNP: Twitches and jerks (2), functional movement disorder (1), non-specified (4).

b

PNP: None. NNP: History of right arm and leg numbness with weakness due to a right medullary demyelinating plaque, later determined to be due to multiple sclerosis (1).

c

PNP: Lumbosacral radiculitis (1). NNP: None.

d

PNP: Self-reported variation of heart rate (10), POTS (3), variation of blood pressure (1), orthostatic hypotension (0), other non-defined attributed to variation of heart rate and blood pressure. NNP: Self-reported variation of heart rate (39), variation of blood pressure (19), POTS (16) orthostatic hypotension (9).

e

PNP: Nausea (8), vomiting (2), diarrhea (14), gastroparesis (0). NNP: Nausea (47), vomiting (13), diarrhea (0), gastroparesis (0).

f

Evaluated for in person visits only.

g

PNP: Decreased visual acuity, mild (2), right VII nerve weakness (1), obscuration of disc margins (1), sustained end gaze nystagmus (1). NNP: Decreased visual acuity ranging from mild to severe (4), facial nerve paralysis (3), nystagmus, non-specified (2), baseline optic neuropathy due to NAION (1), left afferent pupillary defect and pale optic nerve (1), hearing decreased in right side (2) with Weber lateralizing to the right (1), right hypertropia with left supraduction (1).

h

1NNP patient reported auditory hallucinations, hearing music/melody for a few seconds 2 to 3 times a week.

i

1 NNP patient reported fluctuations in body temperature.